BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33331144)

  • 1. Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinomas in the urinary bladder: Cytopathologic correlation of 72 cases.
    Yoo Y; Choi E; Lee DH; Park S; Sung SH
    Diagn Cytopathol; 2021 Mar; 49(3):367-373. PubMed ID: 33331144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary tract cytology showing variant morphology and divergent differentiation.
    Arshia A; Hassan FA; Hensley PJ; Allison DB
    Cytopathology; 2024 Mar; 35(2):199-212. PubMed ID: 37919868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.
    Shah RB; Montgomery JS; Montie JE; Kunju LP
    Urol Oncol; 2013 Nov; 31(8):1650-5. PubMed ID: 22608543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
    Suo L; Vega I; Thrall M
    J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
    Ylagan LR; Humphrey PA
    Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
    Lonati C; Baumeister P; Ornaghi PI; Di Trapani E; De Cobelli O; Rink M; Karnes RJ; Poyet C; Simone G; Afferi L; Necchi A; Briganti A; Montorsi F; Krajewski W; Antonelli A; Cerruto MA; Zamboni S; Simeone C; Mordasini L; Mattei A; Moschini M;
    Eur Urol Focus; 2022 Mar; 8(2):457-464. PubMed ID: 33867307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
    Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
    Warrick JI; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff D; Chen G
    Virchows Arch; 2017 Sep; 471(3):337-345. PubMed ID: 28721490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
    Moschini M; Shariat SF; Lucianò R; D'Andrea D; Foerster B; Abufaraj M; Bandini M; Dell'Oglio P; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Clin Genitourin Cancer; 2017 Aug; 15(4):e603-e607. PubMed ID: 28040422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.
    Straccia P; Martini M; Sacco E; Bassi PF; Pierconti F
    Diagn Cytopathol; 2020 Feb; 48(2):111-117. PubMed ID: 31650714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Approach to Nonurothelial Malignancies of the Urinary Bladder in Urine Cytology.
    Lew M
    Adv Anat Pathol; 2022 Nov; 29(6):412-422. PubMed ID: 35687328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine Cytology Findings in Cases of Pseudocarcinomatous Urothelial Hyperplasia of the Bladder Often Represent a Diagnostic Challenge.
    Velez Torres JM; Gonzalez ML; Duarte EM; Zein-Sabatto B; Aron M; Gupta NS; Kerr DA; Netto GJ; Jorda M; Kryvenko ON
    Arch Pathol Lab Med; 2023 Jun; 147(6):716-721. PubMed ID: 36191340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
    Koyuncuer A
    Asian Pac J Cancer Prev; 2015; 16(7):2871-7. PubMed ID: 25854375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
    Kim JM; Lee J; Sung SH
    Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine cytology in the detection of renal cell carcinomas - a territory-wide multi-institutional retrospective review of more than 2 decades.
    Li JJX; Ng JKM; Tang CY; Chan BCH; Chan SY; Law JHN; Teoh JY; VandenBussche CJ; Tse GM
    Cancer Cytopathol; 2024 Mar; 132(3):186-192. PubMed ID: 38329359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.
    Nagumo Y; Kojima T; Shiga M; Kandori S; Kimura T; Takaoka EI; Onozawa M; Miyazaki J; Kawai K; Ishikawa H; Sakurai H; Nishiyama H
    Int J Clin Oncol; 2020 Feb; 25(2):354-361. PubMed ID: 31595343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.